A community challenge to evaluate RNA-seq, fusion detection, and isoform quantification methods for cancer discovery.

Cancer Cloud compute DREAM Challenge RNA fusion RNA-seq benchmark crowd-sourced evaluation isoform quantification

Journal

Cell systems
ISSN: 2405-4720
Titre abrégé: Cell Syst
Pays: United States
ID NLM: 101656080

Informations de publication

Date de publication:
18 08 2021
Historique:
received: 01 10 2019
revised: 15 09 2020
accepted: 25 05 2021
pubmed: 20 6 2021
medline: 7 4 2022
entrez: 19 6 2021
Statut: ppublish

Résumé

The accurate identification and quantitation of RNA isoforms present in the cancer transcriptome is key for analyses ranging from the inference of the impacts of somatic variants to pathway analysis to biomarker development and subtype discovery. The ICGC-TCGA DREAM Somatic Mutation Calling in RNA (SMC-RNA) challenge was a crowd-sourced effort to benchmark methods for RNA isoform quantification and fusion detection from bulk cancer RNA sequencing (RNA-seq) data. It concluded in 2018 with a comparison of 77 fusion detection entries and 65 isoform quantification entries on 51 synthetic tumors and 32 cell lines with spiked-in fusion constructs. We report the entries used to build this benchmark, the leaderboard results, and the experimental features associated with the accurate prediction of RNA species. This challenge required submissions to be in the form of containerized workflows, meaning each of the entries described is easily reusable through CWL and Docker containers at https://github.com/SMC-RNA-challenge. A record of this paper's transparent peer review process is included in the supplemental information.

Identifiants

pubmed: 34146471
pii: S2405-4712(21)00207-6
doi: 10.1016/j.cels.2021.05.021
pmc: PMC8376800
mid: NIHMS1710731
pii:
doi:

Substances chimiques

Protein Isoforms 0
RNA 63231-63-0

Types de publication

Journal Article Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

827-838.e5

Subventions

Organisme : NCI NIH HHS
ID : U24 CA180922
Pays : United States
Organisme : NCI NIH HHS
ID : U24 CA209923
Pays : United States
Organisme : NIGMS NIH HHS
ID : R01 GM109031
Pays : United States
Organisme : NCI NIH HHS
ID : U24 CA143799
Pays : United States
Organisme : NCI NIH HHS
ID : P30 CA016042
Pays : United States
Organisme : NCI NIH HHS
ID : U24 CA210957
Pays : United States
Organisme : NCI NIH HHS
ID : R01 CA180778
Pays : United States
Organisme : NCI NIH HHS
ID : R50 CA211461
Pays : United States
Organisme : CCR NIH HHS
ID : HHSN261200800001C
Pays : United States
Organisme : NCI NIH HHS
ID : HHSN261200800001E
Pays : United States
Organisme : NCI NIH HHS
ID : U24 CA210990
Pays : United States

Investigateurs

Hongjiu Zhang (H)
Yifan Wang (Y)
Yuanfang Guan (Y)
Cu Nguyen (C)
Christopher Sugai (C)
Alokkumar Jha (A)
Jing Woei Li (JW)
Alexander Dobin (A)

Informations de copyright

Copyright © 2021 The Authors. Published by Elsevier Inc. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of interests The authors declare no competing interests.

Références

PLoS One. 2018 May 1;13(5):e0196588
pubmed: 29715310
Cell. 2019 Feb 7;176(4):831-843.e22
pubmed: 30735634
Brief Bioinform. 2019 Mar 22;20(2):492-503
pubmed: 29045534
BMC Bioinformatics. 2011 Aug 04;12:323
pubmed: 21816040
PLoS One. 2010 Aug 18;5(8):e12271
pubmed: 20805885
Am J Blood Res. 2018 Dec 10;8(4):29-56
pubmed: 30697448
Bioinformatics. 2013 Jan 1;29(1):15-21
pubmed: 23104886
Nat Methods. 2012 Jul 15;9(8):796-804
pubmed: 22796662
Nat Methods. 2017 Apr;14(4):417-419
pubmed: 28263959
Nat Biotechnol. 2018 May 9;36(5):391-392
pubmed: 29734317
Nature. 2019 May;569(7757):503-508
pubmed: 31068700
Cell Rep. 2018 Apr 3;23(1):227-238.e3
pubmed: 29617662
Genome Biol. 2016 Apr 23;17:74
pubmed: 27107712
Genome Biol. 2018 Nov 6;19(1):188
pubmed: 30400818
Mob DNA. 2015 Jun 02;6:11
pubmed: 26045719
Methods Mol Biol. 2017;1611:199-217
pubmed: 28451981
Genome Biol. 2019 Oct 21;20(1):213
pubmed: 31639029
Int J Cancer. 2016 Jul 15;139(2):373-82
pubmed: 26949921
Cell. 2011 Mar 4;144(5):646-74
pubmed: 21376230
Front Genet. 2011 Dec 26;2:92
pubmed: 22303386
J Mol Diagn. 2018 Jul;20(4):495-511
pubmed: 29929942
Bioinform Biol Insights. 2015 Nov 15;9(Suppl 1):29-46
pubmed: 26609224
Theory Biosci. 2012 Dec;131(4):281-5
pubmed: 22872506
Nat Rev Genet. 2010 Jan;11(1):31-46
pubmed: 19997069
Nat Biotechnol. 2016 May;34(5):525-7
pubmed: 27043002
Sci Rep. 2016 Feb 10;6:21597
pubmed: 26862001
Nucleic Acids Res. 2015 Oct 15;43(18):e116
pubmed: 26040699
Nat Commun. 2019 May 16;10(1):2198
pubmed: 31097696
Nature. 2009 Mar 5;458(7234):97-101
pubmed: 19136943
Genome Biol. 2019 Sep 10;20(1):195
pubmed: 31506093
Nat Genet. 2013 Jun;45(6):580-5
pubmed: 23715323
Mol Cancer Res. 2017 Sep;15(9):1206-1220
pubmed: 28584021
Cancer Cell. 2006 Dec;10(6):515-27
pubmed: 17157791
Cell. 2000 Jan 7;100(1):57-70
pubmed: 10647931
Neoplasia. 2008 Feb;10(2):177-88
pubmed: 18283340
Nat Methods. 2018 Jun;15(6):407
pubmed: 29855579
Methods Mol Biol. 2016;1418:283-334
pubmed: 27008021
Nucleic Acids Res. 2016 Jan 4;44(D1):D746-52
pubmed: 26481351
Nat Methods. 2013 Jan;10(1):71-3
pubmed: 23160280
BMC Genomics. 2017 Aug 7;18(1):583
pubmed: 28784092
Genome Biol. 2015 Jul 23;16:150
pubmed: 26201343

Auteurs

Allison Creason (A)

Biomedical Engineering, Oregon Health and Science University, Portland, OR 97239, USA.

David Haan (D)

Biomolecular Engineering and UC Santa Cruz Genome Institute, University of California, Santa Cruz, Santa Cruz, CA, USA.

Kristen Dang (K)

Sage Bionetworks, Seattle, WA, USA.

Kami E Chiotti (KE)

Biomedical Engineering, Oregon Health and Science University, Portland, OR 97239, USA.

Matthew Inkman (M)

The Genome Institute, Washington University School of Medicine, 4444 Forest Park Avenue, St. Louis, MO 63110, USA.

Andrew Lamb (A)

Sage Bionetworks, Seattle, WA, USA.

Thomas Yu (T)

Sage Bionetworks, Seattle, WA, USA.

Yin Hu (Y)

Sage Bionetworks, Seattle, WA, USA.

Thea C Norman (TC)

Sage Bionetworks, Seattle, WA, USA.

Alex Buchanan (A)

Biomedical Engineering, Oregon Health and Science University, Portland, OR 97239, USA.

Marijke J van Baren (MJ)

Biomolecular Engineering and UC Santa Cruz Genome Institute, University of California, Santa Cruz, Santa Cruz, CA, USA.

Ryan Spangler (R)

Biomedical Engineering, Oregon Health and Science University, Portland, OR 97239, USA.

M Rick Rollins (MR)

Biomedical Engineering, Oregon Health and Science University, Portland, OR 97239, USA.

Paul T Spellman (PT)

Biomedical Engineering, Oregon Health and Science University, Portland, OR 97239, USA.

Dmitri Rozanov (D)

Biomedical Engineering, Oregon Health and Science University, Portland, OR 97239, USA.

Jin Zhang (J)

The Genome Institute, Washington University School of Medicine, 4444 Forest Park Avenue, St. Louis, MO 63110, USA.

Christopher A Maher (CA)

The Genome Institute, Washington University School of Medicine, 4444 Forest Park Avenue, St. Louis, MO 63110, USA.

Cristian Caloian (C)

Computational Biology, Ontario Institute for Cancer Research, Toronto, Canada.

John D Watson (JD)

Computational Biology, Ontario Institute for Cancer Research, Toronto, Canada.

Sebastian Uhrig (S)

Division of Applied Bioinformatics, German Cancer Research Center (DKFZ) and Faculty of Biosciences, Heidelberg University, Heidelberg, Germany.

Brian J Haas (BJ)

Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA.

Miten Jain (M)

Biomolecular Engineering and UC Santa Cruz Genome Institute, University of California, Santa Cruz, Santa Cruz, CA, USA.

Mark Akeson (M)

Biomolecular Engineering and UC Santa Cruz Genome Institute, University of California, Santa Cruz, Santa Cruz, CA, USA.

Mehmet Eren Ahsen (ME)

Icahn School of Medicine at Mount Sinai, Department of Genetics and Genomic Sciences, One Gustave Levy Place, New York, NY 1498, USA.

Gustavo Stolovitzky (G)

Icahn School of Medicine at Mount Sinai, Department of Genetics and Genomic Sciences, One Gustave Levy Place, New York, NY 1498, USA; IBM T.J. Watson Research Center, 1101 Kitchawan Road, Route 134, Yorktown Heights, NY 10598, USA.

Justin Guinney (J)

Sage Bionetworks, Seattle, WA, USA.

Paul C Boutros (PC)

Computational Biology, Ontario Institute for Cancer Research, Toronto, Canada; Departments of Medical Biophysics and Pharmacology & Toxicology, University of Toronto, Toronto, Canada; Departments of Human Genetics and Urology, University of California, Los Angeles, Los Angeles, CA, USA.

Joshua M Stuart (JM)

Biomolecular Engineering and UC Santa Cruz Genome Institute, University of California, Santa Cruz, Santa Cruz, CA, USA.

Kyle Ellrott (K)

Biomedical Engineering, Oregon Health and Science University, Portland, OR 97239, USA. Electronic address: ellrott@ohsu.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH